These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17039784)

  • 1. [Preparation, characterization, and pulmonary delivery of rifapentine liposomes modified by lauric diethanolamide].
    Shu JY; Quan XY; Shu Y; Guang YP; Liu YC
    Yao Xue Xue Bao; 2006 Aug; 41(8):761-4. PubMed ID: 17039784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilization of cationic rifampicin-loaded liposomes on polystyrene for drug-delivery applications.
    Pasquardini L; Lunelli L; Vanzetti L; Anderle M; Pederzolli C
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):265-72. PubMed ID: 18083351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of nanoemulsions for intravenous delivery of rifampicin.
    Ahmed M; Ramadan W; Rambhu D; Shakeel F
    Pharmazie; 2008 Nov; 63(11):806-11. PubMed ID: 19069240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of lung targeting azithromycin liposomes and its tissue distribution in mice].
    Wang JS; Zhu JB; Lu RQ; Shen W
    Yao Xue Xue Bao; 2005 Mar; 40(3):274-8. PubMed ID: 15952603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach.
    Patil-Gadhe A; Pokharkar V
    Pulm Pharmacol Ther; 2014 Apr; 27(2):197-207. PubMed ID: 23916767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
    Singh H; Jindal S; Singh M; Sharma G; Kaur IP
    Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design.
    Petkar KC; Chavhan S; Kunda N; Saleem I; Somavarapu S; Taylor KMG; Sawant KK
    AAPS PharmSciTech; 2018 May; 19(4):1758-1772. PubMed ID: 29589222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
    Ning M; Gu Z; Pan H; Yu H; Xiao K
    Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy.
    Gürsoy A; Kut E; Ozkirimli S
    Int J Pharm; 2004 Mar; 271(1-2):115-23. PubMed ID: 15129978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes for drug delivery to the lungs by nebulization.
    Zaru M; Mourtas S; Klepetsanis P; Fadda AM; Antimisiaris SG
    Eur J Pharm Biopharm; 2007 Nov; 67(3):655-66. PubMed ID: 17540552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis.
    Scolari IR; Páez PL; Sánchez-Borzone ME; Granero GE
    AAPS PharmSciTech; 2019 Jan; 20(2):67. PubMed ID: 30627867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
    Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W
    Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-coated liposomes for delivery to lungs by nebulisation.
    Zaru M; Manca ML; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
    Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
    Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.
    He S; Zhu J; Xie F
    Pharmazie; 2010 Jul; 65(7):467-70. PubMed ID: 20662312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified rifampin nanoparticles: Increased solubility with slow release Rate.
    Farnia P; Velayati AA; Mollaei S; Ghanavi J
    Int J Mycobacteriol; 2017; 6(2):171-176. PubMed ID: 28559520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of amylopectin modified dipyridamole liposome and its tissue distribution in mice].
    Cheng J; Zhu JB; Yang SX; Wang CB
    Yao Xue Xue Bao; 2006 Mar; 41(3):277-81. PubMed ID: 16759003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted drug delivery of Rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome.
    Gaur PK; Mishra S; Gupta VB; Rathod MS; Purohit S; Savla BA
    Drug Dev Ind Pharm; 2010 Jun; 36(6):638-46. PubMed ID: 20136485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro].
    Xiao CJ; Qi XR; Aini W; Wei SL
    Yao Xue Xue Bao; 2003 Feb; 38(2):133-7. PubMed ID: 12778750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.